For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Intervention | This is a single arm intervention using Everolimus. Everyone in the study will receive Everolimus at a starting dose of 10 mg daily and will be adjusted up or down by 2.5 mg at 2-week intervals to attain a trough concentration of 5-15 ng/mL. | 0 | None | 0 | 22 | 22 | 22 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Stomatitis | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Upper Respiratory Infection/Cough/Sinus Infection/Pneumonia/Pharyngitis | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Gastrointestinal (GI) Upset | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Folliculitis/Impetigo/Rash/Itching | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Decreased Per Oral Intake/Weight loss | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Headache | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Tooth Infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Urinary Tract Infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Fatigue | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Erythema Nodosum | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Vaginitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Thrush | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Pneumonitis | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Bladder Leakage | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Pheochromocytoma | NON_SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| Ingrown Toenail | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Nose Bleed | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Hypercholesterolemia | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Left Side Numbness | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Biopsy Infection | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Foggy Hearing | NON_SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | None | View |
| Ammenorrhea | NON_SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | None | View |
| Ovarian Cyst | NON_SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | None | View |